Mr. Larry Bortles reports

PATIENT GROWTH EQUALS BIG DATA FOR KNALYSIS TECHNOLOGIES AND CANADA HOUSE WELLNESS GROUP

Knalysis Technologies, a subsidiary of Canada House Wellness Group Inc., now has more than 12,000 medical cannabis patients on its software platforms, representing 6 per cent of the registered base in all of Canada. Its clinicians are providing the best care possible to these patients through Knalysis's sister division, Marijuana for Trauma Inc., and its 11 clinics across Canada. Coupled with Knalysis's United States client base, more than 32 million data points for medical cannabis treatment have been captured to date.

As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips. This information is critical to breaking away from anecdotal evidence of the efficacy of medical marijuana. It's simply not good enough anymore to prescribe a treatment regimen based on what "we have heard" works. Patients deserve better and Knalysis platforms are ensuring that they are getting it. Knalysis Technologies' proprietary suite of software is helping clients grow their business through major efficiency gains and improving patient outcomes by interpreting and making good use of the significant amount of data that flows through its data platforms.

Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 patients to 20,000 patients into its platforms by midyear, adding tens of millions more data points for the benefit of its analytics subscribers. All of this strengthens Knalysis' recommendations for patient treatments and their health outcomes. This vast amount of data has led to talks with key industry reporting partners and the company expects more exciting news on this front soon. All of this progress ultimately benefits patients who have been seeking the right kind of treatment for their ailments for decades. Getting away from anecdotal evidence and proving the efficacy of medical marijuana is the key to ensuring that access to this treatment is secured for the long-term.

About Knalysis Technologies

Knalysis Technologies is part of the Canada House Wellness Group, a publicly traded Canadian company with one of the largest networks of cannabis clinics in Canada. It envisioned a need for health technology connecting every aspect of the medical marijuana field, and pioneered software to seamlessly link physician, provider and patient. Purpose-built in the company's own clinics, Knalysis' suite of software has been battle-tested with thousands of patients for over four years, treating a broad range of ailments and symptoms.

Canada House Wellness Group Inc.

Canada House is the parent company of Marijuana for Trauma, Knalysis Technologies and Abba Medix Corp. The company's goal is to become a marketplace leader through strategic partnerships, mergers and acquisitions to create a fully integrated cannabis therapy company.

We seek Safe Harbor.